Top Markets
#1 Islamic Coin Islamic Coin +155.81%
#2 Siren Siren +35.79%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.69%
#4 Cysic Cysic +17.80%
#5 Arowana Arowana +15.95%
#6 The Grays Currency The Grays Currency +15.43%
#7 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.93%
#8 Perle Perle +14.38%
#9 aPriori aPriori +14.25%
#10 PulseChain PulseChain +13.90%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Pharmaids Pharmaceuticals Limited Pharmaids Pharmaceuticals Limited

Pharmaids Pharmaceuticals Limited

PHARMAID
Rank in Stocks #31558
Pharmaids Pharmaceuticals Limited, a company founded on March 1, 1989, with its... Pharmaids Pharmaceuticals Limited, a company founded on March 1, 1989, with its headquarters situated in Hyderabad, India, operates within the pharmaceutical industry. Its primary business involves the research, formulation, production, and supply of various medicinal products. The company's offerings specifically include generic medications, active pharmaceutical ingredients (bulk drugs), and essential pharmaceutical intermediates.
Share Price
$0.36407359
Market Cap
$12.84M
Change (1 day)
-1.20%
Change (1 year)
-49.03%
Country
IN
Trade Pharmaids Pharmaceuticals Limited (PHARMAID)

Category

Healthcare
Revenue for Pharmaids Pharmaceuticals Limited (PHARMAID)
Revenue in Aug 2026 TTM: 0
According to Pharmaids Pharmaceuticals Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Pharmaids Pharmaceuticals Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT